X
UCB joins with UK charity to research new epilepsy drugs
https://pharmaphorum.com/news/ucb-joins-with-uk-charity-to-research-new-epilepsy-drugs/
UCB
FDA approves UCB’s Cimzia in plaque psoriasis
The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis
FDA approves Pfizer’s Besponsa in aggressive blood cancer
Besponsa becomes first of its kind indicated for rare type of acute lymphoblastic leukaemia.
1 2
